Cancer as development gone awry: The case for bisphenol-A as a carcinogen

Journal of Developmental Origins of Health and Disease

Volumn 2, Issue 1, 2011, Pages 9-16

  Sonnenschein, C ^a   Wadia, P R ^a   Rubin, B S ^a   Soto, A M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endocrine disruptors; fetal mammary gland development; fetal origins of adult disease; stromaepithelium interactions; tissue organization field theory

Indexed keywords

EID: 84867478065     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174411000043     Document Type: Conference Paper

References (64)

1. Markey CM, Coombs MA, Sonnenschein C, Soto AM. Mammalian development in a changing environment: Exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev. 2003; 5, 1-9.
2. Vandenberg LN, Maffini MV, Schaeberle CM, et al. Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol. 2008; 3-4, 210-219.
3. Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol. 2007; 23, 383-390. (Pubitemid 46602926)
4. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin Mol Teratol. 2005; 73, 478-480. (Pubitemid 41045293)
5. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol-A affects body weight, patterns of estrous cyclicity and plasma LH levels. Environ Health Perspect. 2001; 109, 675-680. (Pubitemid 32785423)
6. Herbst AL, Bern HA. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy, 1988. Thieme-Stratton, New York.
7. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 1980; 40, 3988-3999. (Pubitemid 10030417)
8. Boylan ES, Calhoon RE. Transplacental action of diethylstilbestrol on mammary carcinogenesis in female rats given one or two doses of 7,12-dimethylbenz(a)anthracene. Cancer Res. 1983; 43, 4879-4884. (Pubitemid 13015871)
9. Soto AM, Sonnenschein C. Environmental causes of cancer: Endocrine disruptors as carcinogens. Nat Rev Endocrinol. 2010; 6, 363-370.
10. Gilbert SF. Mechanisms for the environmental regulation of gene expression: Ecological aspects of animal development. J Biosci. 2005; 30, 65-74. (Pubitemid 40571501)
11. Moss L. What Genes Can't Do, 2003. MIT Press, Cambridge, MA.
12. Soto AM, Sonnenschein C. Emergentism as a default: Cancer as a problem of tissue organization. J Biosci. 2005; 30, 103-118. (Pubitemid 40571505)
13. Schrodinger E. What is Life? The Physical Aspect of the Living Cell, 1945. The University Press, Cambridge, England.
14. Barker DJP, Hanson MA. Altered regional blood flow in the fetus: The origins of cardiovascular disease? Acta Paediatricia. 2004; 93, 1559-1560.
15. Thompson DW. On Growth and Form, 1942. Cambridge University Press, Cambridge.
16. Ingber DE. Mechanical control of tissue morphogenesis during embryological development. Int J Dev Biol. 2006; 50, 255-266.
17. Patwari P, Lee RT. Mechanical control of tissue morphogenesis. Circ Res. 2008; 103, 234-243.
18. Soto AM, Sonnenschein C, Miquel P-A. On physicalism and downward causation in developmental and cancer biology. Acta Biotheor. 2008; 56, 257-274.
19. Sonnenschein C, Soto AM. The Society of Cells: Cancer and Control of Cell Proliferation, 1999. Springer Verlag, New York.
20. Noble D. The Music of Life: Biology beyond the Genome, 2006. Oxford University Press, Oxford.
21. Triolo VA. Nineteenth century foundations of cancer research advances in tumor pathology, nomenclature, and theories of oncogenesis. Cancer Res. 1965; 25, 76-98.
22. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer. 2002; 2, 331-342.
23. Soto AM, Sonnenschein C. The somatic mutation theory of cancer: Growing problems with the paradigm? BioEssays. 2004; 26, 1097-1107.
24. Baker SG, Cappuccio A, Potter JD. Research on early-stage carcinogenesis: Are we approaching paradigm instability? J Clin Oncol. 2010; 28, 3215-3218.
25. Maffini MV, Calabro JM, Soto AM, Sonnenschein C. Stromal regulation of neoplastic development: Age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol. 2005; 67, 1405-1410. (Pubitemid 41541426)
26. Skakkebaek NE, Meyts ER, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: An environmental connection? APMIS. 1998; 106, 3-12.
27. Soto AM, Sonnenschein C. Environmental causes of cancer: Endocrine disruptors as carcinogens. Nat Rev Endocrinol. 2010; 6, 363-370.
28. Mittendorf R. Teratogen update: Carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology. 1995; 51, 435-445.
29. Herbst AL, Anderson D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6, 343-346.
30. Hatch EE, Troisi R, Wise LA, et al. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006; 164, 682-688. (Pubitemid 44453497)
31. Palmer JR, Wise LA, Hatch EE, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidem Biomar. 2006; 15, 1509-1514. (Pubitemid 44299324)
32. Lemmen JG, Broekhof JLM, Kuiper GGJM, et al. Expression of estrogen receptor alpha and beta during mouse embryogenesis. Mech Dev. 1999; 81, 163-167. (Pubitemid 29183054)
33. Veltmaat JM, Mailleux AA, Thiery JP, Bellusci S. Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation. 2003; 71, 1-17. (Pubitemid 38230415)
34. Vandenberg LN, Maffini MV, Wadia PR, et al. Exposure to the xenoestrogen bisphenol-A alters development of the fetal mammary gland. Endocrinology. 2007; 148, 116-127. (Pubitemid 46021444)
35. Humphreys RC, Krajewska M, Krnacik S, et al. Apoptosis in the terminal end bud of the murine mammary gland: A mechanism of ductal morphogenesis. Development. 1996; 122, 4013-4022. (Pubitemid 27033895)
36. Daniel CW, Smith GH. The mammary gland: A model for development. J Mammary Gland Biol Neoplasia. 1999; 4, 3-8.
37. Soto AM, Sonnenschein C. Environmental causes of cancer: Endocrine disruptors as carcinogens. Nat Rev Endocrinol. 2010; 6, 363-370.
38. Markey CM, Luque EH, Munoz de Toro MM, Sonnenschein C, Soto AM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod. 2001; 65, 1215-1223. (Pubitemid 32927590)
39. Munoz de Toro MM, Markey CM, Wadia PR, et al. Perinatal exposure to bisphenol A alters peripubertal mammary gland development in mice. Endocrinology. 2005; 146, 4138-4147. (Pubitemid 41175786)
40. Wadia PR, Vandenberg LN, Schaeberle CM, et al. Perinatal bisphenol-A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect. 2007; 115, 592-598. (Pubitemid 46585532)
41. Rothschild TC, Boylan ES, Calhoon RE, Vonderhaar BK. Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res. 1987; 47, 4508-4516. (Pubitemid 17124327)
42. Schor SL, Schor AM, Howell A, Haggie J. The possible role of abnormal fibroblasts in the pathogenesis of breast cancer. In Breast Cancer: Scientific and Chemical Progress (eds. Rich MA, Hagar JC, Lopez DM), 1988; pp. 142-157. Kluwer Academic Publishers, Boston.
43. Durando M, Kass L, Piva J, et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect. 2007; 115, 80-86. (Pubitemid 46050286)
44. Jenkins S, Raghuraman N, Eltoum I, et al. Oral exposure to bisphenol A increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect. 2009; 117, 910-915.
45. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996; 104, 938-967. (Pubitemid 26372400)
46. Grubbs CJ, Peckham JC, Cato KD. Mammary carcinogenesis in rats in relation to age at time of N-nitroso-N-methylurea administration. J Nat Cancer Inst. 1983; 70, 209-212. (Pubitemid 13138353)
47. Land CE, Tokunaga M, Koyama K, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res. 2003; 160, 707-717. (Pubitemid 37521714)
48. Ho S-M, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol a increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006; 66, 5624-5632. (Pubitemid 43927114)
49. Weinberg RA. The Biology of Cancer, 2006. Taylor & Francis, New York.
50. Sonnenschein C, Soto AM. Theories of carcinogenesis: An emerging perspective. Semin Cancer Biol. 2008; 18, 372-377.
51. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci. 2004; 117, 1495-1502. (Pubitemid 38559824)
52. Robboy SJ, Welch WR, Young RH, et al. Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol. 1982; 60, 546-551. (Pubitemid 12037351)
53. Newbold RR, McLachlan JA. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res. 1982; 42, 2003-2011. (Pubitemid 12103405)
54. Kurita T, Mills A, Cunha GR. Roles of p63 in the diethylstilbestrol- induced cervicovaginal adenosis. Development. 2004; 131, 1639-1649. (Pubitemid 38559290)
55. Cunha GR. Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Mullerian ducts and urogenital sinus during development of the uterus and vagina in mice. J Exp Zool. 1976; 196, 361-370.
56. Yin Y, Lin C, Ma L. MSX2 promotes vaginal epithelial differentiation and wolffian duct regression and dampens the vaginal response to diethylstilbestrol. Mol Endocrinol. 2006; 20, 1535-1546. (Pubitemid 43967562)
57. Weber-Hall SJ, Phippard DJ, Niemeyer CC, Dale TC. Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation. 1994; 57, 205-214. (Pubitemid 24296447)
58. Phippard DJ,Weber-Hall SJ, Sharpe PT, et al. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development. 1996; 122, 2729-2737. (Pubitemid 26326505)
59. Fleming JM, Long EL, Ginsburg E, et al. Interlobular and intralobular mammary stroma: Genotype may not reflect phenotype. BMC Cell Biol. 2008; 9, 46.
60. Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: Hypotheses based on epidemiological evidence. Breast Cancer Res. 2008; 10, 201-214.
61. Provenzano PP, Inman DR, Eliceiri KW, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008; 6, 11.
62. Paszek MJ, Weaver VM. The tension mounts: Mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia. 2004; 9, 325-342. (Pubitemid 41149140)
63. Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8, 241-254. (Pubitemid 41317594)
64. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: An endocrine society scientific statement. Endocr Rev. 2009; 30, 293-342.